The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers

Journal of Neuroscience

Volumn 25, Issue 18, 2005, Pages 4493-4502

  Zhou, Rulun ^a,b   Gray, Neil A ^a,c   Yuan, Peixiong ^a   Li, Xiaoxia ^b   Chen, Jingshan ^a   Chen, Guang ^a   Damschroder Williams, Patricia ^a   Du, Jing ^a   Zhang, Lei ^a,b   Manji, Husseini K ^a,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Columbia University ^*  (United States)

Author keywords

BAG 1; Bipolar disorder; Glucocorticoid; Lithium; Neuroplasticity; Valproate

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; BAG 1 PROTEIN; DEXAMETHASONE; FLUVOXAMINE; GLUCOCORTICOID RECEPTOR; HALOPERIDOL; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; MOOD STABILIZER; NEUROLEPTIC AGENT; PROTEIN BCL 2; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CELL CULTURE; CONTROLLED STUDY; DELIRIUM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HIPPOCAMPUS; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; RAT; REPORTER GENE; STATISTICAL ANALYSIS;

ALKALINE PHOSPHATASE; ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CELL LINE, TUMOR; DEXAMETHASONE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; LITHIUM; MALE; MOLECULAR WEIGHT; NEUROBLASTOMA; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RNA, SMALL INTERFERING; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; VALPROIC ACID;

EID: 20944441740     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4530-04.2005     Document Type: Article

References (39)

1. Birnbaum SG, Yuan PX, Wang M, Vijayraghavan S, Bloom AK, Davis DJ, Gobeske KT, Sweatt JD, Manji HK, Arnsten AF (2004) Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 306:882-884.
2. Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, Modell S, Kunzel H, Muller-Oerlinghausen B, Bauer M (2002) Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Neuropsychopharmacology 27:470-478.
3. Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Muller-Oerlinghausen B, Bauer M (2003) Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Depress Anxiety 17:43-48.
4. Chen G, Yuan PX, Jiang YM, Huang LD, Manji HK (1998) Lithium increases tyrosine hydroxylase levels both in vivo and in vitro. J Neurochem 70:1768-1771.
5. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK (1999) The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72:879-882.
6. Coyle JT, Duman RS (2003) Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157-160.
7. Coyle JT, Manji HK (2002) Getting balance: drugs for bipolar disorder share target. Nat Med 8:557-558.
8. Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST, Einat H, Manji HK (2004) Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci 24:6578-6589.
9. Duman RS (2002) Synaptic plasticity and mood disorders. Mol Psychiatry 7 [Suppl 1]:S29-S34.
10. Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ (2003) The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. J Pharmacol Exp Ther 305:434-439.
11. Hayashi T, Sakai K, Sasaki C, Itoyama Y, Abe K (2000) Loss of bag-1 immunoreactivity in rat brain after transient middle cerebral artery occlusion. Brain Res 852:496-500.
12. Kanelakis KC, Morishima Y, Dittmar KD, Galigniana MD, Takayama S, Reed JC, Pratt WB (1999) Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery. J Biol Chem 274:34134-34140.
13. Kermer P, Krajewska M, Zapata JM, Takayama S, Mai J, Krajewski S, Reed JC (2002) Bag1 is a regulator and marker of neuronal differentiation. Cell Death Differ 9:405-413.
14. Kermer P, Digicaylioglu MH, Kaul M, Zapata JM, Krajewska M, Stenner-Liewen F, Takayama S, Krajewski S, Lipton SA, Reed JC (2003) BAG1 over-expression in brain protects against stroke. Brain Pathol 13:495-506.
15. Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, Cato AC (1998) RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis. J Biol Chem 273:14620-14625.
16. Kunzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S (2003) Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28:2169-2178.
17. Manji HK, Lenox RH (2000a) The nature of bipolar disorder. J Clin Psychiatry 61 [Supp 13]:42-57.
18. Manji HK, Lenox RH (2000b) Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry 48:518-530.
19. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G (1999) Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 60 [Suppl 2]:27-39.
20. Manji HK, Moore GJ, Rajkowska G, Chen G (2000) Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5:578-593.
21. McEwen BS (1999) Stress and hippocampal plasticity. Annu Rev Neurosci 22:105-122.
22. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, Faulk MW, Koch S, Glitz DA, Jolkovsky L, Manji HK (2000) Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48:1-8.
23. Packham G, Brimmell M, Cleveland JL (1997) Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation. Biochem J 328:807-813.
24. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734-36741.
25. Quiroz JA, Singh J, Gould TD, Denicoff KD, Zarate CA, Manji HK (2004) Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology. Mol Psychiatry 9:756-776.
26. Rybakowski JK, Twardowska K (1999) The dexamethasone/corticotropin- releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 33:363-370.
27. Sapolsky RM (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-935.
28. Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ (1995) Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls. I. Biol Psychiatry 38:797-802.
29. Schneikert J, Hubner S, Martin E, Cato AC (1999) A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity. J Cell Biol 146:929-940.
30. Seidberg NA, Clark RS, Zhang X, Lai Y, Chen M, Graham SH, Kochanek PM, Watkins SC, Marion DW (2003) Alterations in inducible 72-kDa heat shock protein and the chaperone cofactor BAG-1 in human brain after head injury. J Neurochem 84:514-521.
31. Sirois F (2003) Steroid psychosis: a review. Gen Hosp Psychiatry 25:27-33.
32. Song J, Takeda M, Morimoto RI (2001) Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat Cell Biol 3:276-282.
33. Sourisseau T, Desbois C, Debure L, Bowtell DD, Cato AC, Schneikert J, Moyse E, Michel D (2001) Alteration of the stability of Bag-1 protein in the control of olfactory neuronal apoptosis. J Cell Sci 114:1409-1416.
34. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC (1995) Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279-284.
35. Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, Kochel K, Knee D, Scudiero D, Tudor G, Miller GJ, Miyashita T, Yamada M, Reed JC (1998) Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res 58:3116-3131.
36. Takayama S, Xie Z, Reed JC (1999) An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 274:781-786.
37. Wei Q, Lu XY, Liu L, Schafer G, Shieh KR, Burke S, Robinson TE, Watson SJ, Seasholtz AF, Akil H (2004) Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc Natl Acad Sci USA 101:11851-11856.
38. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS (2004) Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci USA 101:3973-3978.
39. Yang X, Chernenko G, Hao Y, Ding Z, Pater MM, Pater A, Tang SC (1998) Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells. Oncogene 17:981-989.